PETS — PetMed Express Cashflow Statement
0.000.00%
Last trade - 00:00- $37.39m
- $15.98m
- $179.02m
Annual cashflow statement for PetMed Express, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 21.1 | 5.14 | -7.46 | -6.27 | -57.3 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 4.71 | 6.83 | 7.19 | -5.02 | 28 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.71 | 13.9 | -2.76 | 3.72 | -8.39 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 18.5 | 27.8 | 4.32 | 4.72 | -28.4 |
| Capital Expenditures | -1.75 | -5.26 | -4.51 | -5.11 | -4.62 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -5 | -36.2 | 0 | 0 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.75 | -10.3 | -40.7 | -5.11 | -4.62 |
| Financing Cash Flow Items | — | — | — | — | -0.278 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -24.4 | -24.5 | -12.4 | -0.181 | -0.299 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.64 | -6.99 | -48.8 | -0.576 | -33.3 |